About Us
Abogen Life Science Pte Ltd is a wholly owned subsidiary of Abogen Therapeutics Limited invested by Softbank and Temasek. Abogen is an industry-leading clinical-stage biotech company, dedicated to the development of transformative medicines through RNA innovations. The company has built full-scale in-house capabilities to support the entire mRNA durg development cycle: from protein engineering, mRNA sequence design and synthesis, lipid nanoparticle(LNP) delivery, formulation, and all the way to commercial-scale manufacturing.
Our services: hollistic category of transformative therapies
Abogen provides a world-class mRNA Platform of ground-breaking record in mRNA therapeutics with advanced safety, efficacy and accessibility. The company is developing mRNA-based therapeutics for the treatment of cancer and infectious diseases.
A opened-minded company culture with high standard inclusion, collaboration and innovation
Abogen provides a reinforced mission and fulfillment job environment. Please contact us if you are interested in joining in us.